Chapter 7: Sexually Transmitted and Other Infections

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

What if I told you that a product heavily marketed for decades to protect people from infections was like actually giving a deadly virus a microscopic back door right into the bloodstream.

I mean, we usually think of defense as putting up a physical barrier, right?

But in the world of reproductive anatomy,

the wrong kind of barrier can just completely destroy the body's natural defenses.

Right.

You're talking about noxinol 9, the chemical spermicide.

For a long time, the assumption was just, you know, if it kills sperm, it must neutralize pathogens too.

But the reality is that N9 acts kind of like a harsh detergent.

Wow.

Just completely stripping the tissue.

Exactly.

It chemically strips the lipids from the cell membranes.

So when it's applied to the delicate vaginal or rectal epithelium, it creates these microscopic abrasions and those tiny tears act as a direct portal for HIV and other pathogens, which drastically increases transmission rates.

So we're actively tearing down the very fortress we're trying to reinforce.

Well, welcome to this deep dive.

On behalf of the Last Minute Lecture team, we are so thrilled you're here with us today.

We really are.

Today, our mission is to give you a supportive one -on -one tutoring session covering chapter seven of your maternity and women's health care textbook.

We're looking at sexually transmitted and other infections.

Yeah.

And we're going to trace the pathophysiology, the clinical assessments, and, you know, those crucial nursing interventions and the exact flow of your material.

That way, these foundational concepts build naturally into the clinical reasoning you'll need for your exams and your patient care.

Exactly.

OK, let's unpack this.

So to set the stage,

reproductive tract infections are just a massive umbrella, right?

Huge.

It includes sexually transmitted infections, which are caused by over 30 distinct organisms, plus all those other common localized vaginal infections.

And the public health footprint here is just staggering.

In 2018 alone, the U .S.

saw nearly 26 million new STIs.

26 million?

That's unbelievable.

I know.

And it creates an annual financial burden of almost $16 billion.

And you know, the most crucial demographic detail for you as a future nurse listening to this is that almost half of those 26 million new infections occurred in young people.

We're talking ages 15 to 24.

Right, which forces a completely different clinical approach, honestly.

When half your patient population for a disease category is adolescents and young adults, your primary nursing intervention can't just be dispensing antibiotics.

Yeah, you have to get ahead of it.

Exactly.

It has to be education.

That is the core of primary prevention, you know, stopping the pathogen before it ever breaches the body.

So things like vaccines, condom education, and behavioral counseling all fall into this primary category.

And then secondary prevention is the backup plan, right?

Like rapid diagnosis and treatment to stop the spread and prevent any irreversible anatomical damage.

You nailed it.

But to do either of those effectively, you have to talk to your patient about their sex life without making them feel judged.

And that can be tricky.

Yeah, totally.

But the CDC actually provides a framework for this, right?

It's called the five P's.

That's partners,

practices, protection, past history, and pregnancy intention.

Right.

The five P's.

They are so incredibly helpful in practice.

I always have to think of the five P's kind of like a pre -flight safety checklist.

Like you don't read the safety protocols to interrogate the passengers, you know.

You do it to establish a routine objective baseline for their safe navigation.

That's a great analogy.

By asking every single patient the exact same structured questions, you take the stigma completely out of the room.

And taking that stigma away allows for an honest conversation about risk reduction, which brings us to table 7 .1 in your textbook.

Behaviors really exist on a spectrum.

They do.

The safest practices eliminate fluid exchange and mucosal contact entirely.

So that's abstinence or mutual masturbation with intact skin.

And then moving down the table, you have low or potential risk, correct?

Yeah.

That involves using physical barriers correctly during intercourse or oral sex.

And then of course, high risk behaviors include unprotected intercourse or sharing needles and sex toys.

But a really critical piece of clinical reasoning here is recognizing reproductive coercion.

Like we often assume that if a patient isn't using a condom, it's just a knowledge deficit.

Something we can fix with a pamphlet.

Oh, and that assumption can be so dangerous.

Reproductive coercion is any behavior by a partner that strips a woman of her autonomy to make decisions about her own reproductive health.

Like contraceptive sabotage, right?

Exactly.

This might look like a partner secretly removing a condom, destroying birth control pills, or using threats to prevent barrier use.

If a patient indicates they know how to protect themselves but are just unable to do so, your nursing priority shifts immediately.

Right.

It shifts away from education and straight into patient safety and intimate partner violence screening.

Exactly.

Now, assuming the patient does have autonomy, let's look at the actual barriers they can

Physically, we have external male condoms and internal female condoms.

And the material here matters immensely.

Yeah, because natural skin condoms might block sperm, but their pores are actually large enough to let viruses like HIV or hepatitis just slip right through.

You got it.

They absolutely must be latex or synthetic plastic.

And as we mentioned, right at the top of the deep dive, chemical barriers like N9 spermicides are no longer recommended for STI prevention because of that epithelial damage.

Which leaves us with a newer class of barriers, right?

The non -physical pharmacological ones, like pre -EP and PEP.

Right.

Pre -exposure prophylaxis, or PEP, is a daily oral antiretroviral medication.

It's taken by HIV -negative individuals who are at a high risk.

It maintains this constant level of medication in the bloodstream.

So if HIV does enter the body, the drug just blocks the enzyme the virus needs to replicate.

Precisely.

And then post -exposure prophylaxis, or PP, works in a really similar principle.

But it's a 28 -day regimen started within 72 hours after a high -risk exposure.

It's basically a race to prevent the virus from taking hold.

Okay, so let's shift our clinical focus from how we block these pathogens to what happens when they actually do get in.

We'll start with the bacterial infections.

Good transition.

Yeah.

And the clinical mindset you need here for bacterial pathogens is tracking how a localized asymptomatic infection ascends into the upper reproductive tract to cause systemic damage.

And the prime example of that is chlamydia trachomatis.

Oh, absolutely.

Chlamydia is the most common notifiable STI in the United States.

And its defining characteristic is really its silence.

The vast majority of infected women have zero symptoms whatsoever.

Which is terrifying.

It is.

The bacteria infect the columnar epithelium of the cervix, and it slowly triggers this inflammatory response.

But because there's no pain,

the patient doesn't seek treatment.

And that allows the bacteria to just travel upward, past the cervix, straight into the uterus and fallopian tubes.

Exactly.

So to catch it, we diagnose this silent threat using a nucleic acid amplification test.

That looks for the genetic material of the bacteria in a swab or a urine sample.

And for treatment.

To eradicate it in non -pregnant patients, we use azithromycin, levofloxacin, or doxycycline.

But, and this is a big clinical alert, doxycycline interferes with fetal bone development.

Oh, wow.

So you definitely can't use that in pregnancy.

Right.

For a pregnant patient, we strictly rely on azithromycin or amoxicillin.

Okay.

So right alongside chlamydia is gonorrhea.

And from a public health perspective, this one is just a nightmare scenario.

Rates have skyrocketed like 92 % since 2009.

But the real crisis is the drug resistance, isn't it?

It is a massive crisis.

Nasiria gonorrhea is incredibly adept at acquiring resistance plasmids.

I mean, it has mutated to defeat sulfonamides, penicillins, tetracyclines, and fluoroquinolones.

To the super bug.

It really is.

Because it aggressively mutates to literally pump antibiotics out of its cells, dual therapy isn't even the standard anymore.

The 2021 CDC guidelines recommend a single massive 500 -milligram intramuscular dose of ceftriaxone.

Just to completely overwhelm the bacteria before it can mount a defense.

Exactly.

Hit it hard and fast.

And in adults, gonorrhea can be just as silent as chlamydia, right?

But what about during pregnancy?

I know that during a vaginal delivery, a neonate passing through an infected cervix is exposed to the bacteria.

Right.

And that bacteria attacks the infant's eyes, causing ophthalmia neonutorum.

This rapid conjunctivitis can cause irreversible corneal scarring and blindness literally within days.

Which is exactly why every single newborn receives prophylactic erythromycin ointment in their eyes immediately after birth.

That mechanism is so important to understand.

Definitely.

Okay, then we have a bacterial pathogen that operates on a completely different timeline, syphilis, which is caused by the Spear Shut treponema pallidum.

This one is wild because instead of just ascending the reproductive tract, syphilis uses the bloodstream to invade almost every organ system.

Right.

And it does it in these distinct stages.

Yes.

So primary syphilis features a highly infectious painless ulcer called a chancre at the entry site.

And when that chancre heals on its own, patients often think they're cured, which is the tricky part.

Exactly.

They think it's gone.

But the Spear Shuts are just multiplying systemically.

And this leads to secondary syphilis, which is characterized by a widespread maculopapular rash, particularly on the palms and soles and these highly contagious wart -like lesions called condylamatolata.

And then what happens?

Does it just keep progressing?

Well, eventually the immune system suppresses the active infection into a latent, completely asymptomatic phase.

But if it's left untreated for years, about a third of patients enter tertiary syphilis.

And that's the really bad one, right?

Where the bacteria slowly destroy the cardiovascular system and the central nervous system.

Right.

It's devastating.

But wait, if this disease is so destructive and has such clear stages, why is the testing so convoluted?

I mean, if the non -tripenemal screening tests like the VDRL or RPR give false positives for something as common as pregnancy or just a random autoimmune flare -up, why do we even use them as a baseline for pregnant patients?

It seems like a setup for a panic attack.

It absolutely causes anxiety.

As a nurse, you are going to spend a lot of time counseling panicked patients who are just waiting for confirmation.

But the clinical logic comes down to the mechanism of the test.

And honestly, public health economics.

Oh, so it's a cost thing.

Partially.

You see, the RPR doesn't look for the syphilis bacteria itself.

It looks for antibodies against cardiolipin, which is a lipid released by your own cells when they're damaged by the spirachette.

Because it's testing for general cellular damage, it's cheap, fast, and easy to run on millions of people.

Ah, I see.

But because pregnancy also causes tissue remodeling and lipid release, you get those false positives.

Correct.

So if an RPR is reactive, you must run a treponemal test, like the FT -ABS.

This test is expensive and complex, but it specifically searches for the antibodies created directly against treponema pallidum.

Okay, that makes a lot of sense.

So once you have that confirmation, the gold standard treatment is penicillin G, right?

But you need to anticipate a severe physiological response called the Jerrish -Herxheimer reaction.

Yes, the Jerrish -Herxheimer reaction.

When you administer that penicillin, it doesn't just quietly disable the spirachetes, it literally blows them apart.

Wow.

Yeah, so as millions of syphilis bacteria suddenly rupture, they release massive amounts of lipoproteins and endotoxins directly into the bloodstream.

And the body's immune system detects this massive flood of debris and triggers a cytokine storm, right?

Like, within 24 hours of the injection, the patient develops an acute febrile reaction.

High fever, severe headaches, muscle aches.

Exactly.

They will feel absolutely awful.

And in a pregnant patient, that systemic inflammation and the release of prostaglandins can trigger strong uterine contractions and preterm labor.

Oh, that's a huge clinical alert.

So you have to monitor fetal heart tones and uterine activity really closely after administering that dose.

Absolutely vital.

Okay, now let's trace back to what happens when chlamydia or gonorrhea are not caught early.

The ascending bacteria cause pelvic inflammatory disease, or PID.

Right, PID.

And this is a multi -microbial infectious process, right?

The bacteria migrate from the vagina and cervix up into the sterile upper genital tract, the uterus, fallopian tubes, and ovaries.

And this frequently happens right after a menstrual period when the cervical os is slightly dilated and the protective cervical mucus barrier is just kind of flushed away.

So the immune system attacks the infection inside the fallopian tubes, causing severe inflammation, pelvic pain, fever, and cervical motion tenderness.

But the long -term danger here is actually the healing process.

As the inflammation subsides, the body lays down fibrin to repair the tissue, creating thick scar tissue inside the delicate fallopian tubes.

And that scarring acts like a roadblock.

So a fertilized egg can easily get trapped in the scarred tube, resulting in a sevenfold increase in the risk of a life -threatening ectopic pregnancy.

Exactly.

And this is a really vital transition in our clinical reasoning here.

We focused on bacterial pathogens, where our primary intervention is using antibiotics to eradicate the organism and cure the disease.

But when we encounter viral infections, the clinical paradigm completely changes.

Right.

Because viruses integrate into the host cells.

So our goal shifts from cure to management, viral suppression, and symptom control.

Spot on.

And the most prevalent viral STI is human papillomavirus, or HPV.

Out of roughly 150 strains, we clinically divide the problematic ones by how they alter host cells.

OK.

So you have the oncogenic strains, primarily type 16 and 18.

Those integrate their viral DNA into the host's epithelial cells and actually turn off the tumor suppressor genes, right?

Yes.

And that uncontrolled cellular replication leads to cervical, vaginal, and oropharyngeal cancers.

Then you have the non -oncogenic strains, like type 6 and 11, which cause rapid but benign cellular growth.

And that results in antigenital warts.

So we hunt for those early cellular changes using pap tests.

And we look for the viral DNA itself with high -risk HPV testing.

We can freeze or surgically remove the warts, but we can't excise the virus from the body, right?

We can't.

And that is exactly why the Gardasil 9 vaccine is such a monumental clinical tool.

It generates neutralizing antibodies against nine distinct strains, including the major cancer and wart -causing types.

That's incredible.

It prevents the virus from ever entering the cells in the first place, and it's approved for patients from age 9 all the way up to 45.

Right.

Now moving to herpes simplex virus, or HSV, we see a totally different mechanism of viral persistence.

We traditionally associate HSV1 with oral lesions and HSV2 with genital lesions.

And when the virus first enters the mucosa, it causes a pretty severe systemic primary infection, doesn't it?

It does.

The patient develops multiple painful blister -like ulcers, fever, and swollen lymph nodes as the immune system fights that initial massive viral load.

But the virus is incredibly stealthy.

It travels up the sensory nerve endings and goes completely dormant inside the dorsal root ganglion.

Right.

The immune system can't even touch it there.

So during times of stress, illness, or immunosuppression, the virus travels back down the nerve pathway to the skin, causing a recurrent outbreak.

But these subsequent outbreaks are usually highly localized and a little less severe, right?

Because the body already has circulating antibodies.

Exactly.

Now for a pregnant patient, understanding this shedding mechanism is paramount.

If a neonate is exposed to HSV during a vaginal delivery, the virus attacks the infant's central nervous system, causing devastating encephalopathy or even death.

Wow.

So what does this all mean, especially for a pregnant patient in labor?

The clinical protocol mandates that if the patient has any visible herpetic lesions or prodromal symptoms at the onset of labor, a cesarean birth is strictly required.

Just to bypass the infected tissue entirely.

Right.

And we use antiviral medications like cyclover to suppress viral replication throughout the third trimester, just to minimize the chance of an outbreak at delivery.

Okay, so that's HSV.

Now let's talk about viral hepatitis, which focuses its destruction on the liver, right?

Yes.

Hepatitis A is transmitted via the fecal -oral route, usually from contaminated food.

Hepatitis B is a blood -borne DNA virus that poses a severe threat to a developing fetus.

And we routinely screen pregnant women for Hep B by testing for the turfous antigen, HBZag, right?

We do.

And thankfully, both hepatitis A and B are preventable with vaccines.

The Hep B series is actually a routine part of pediatric care now.

Right.

Now, hepatitis C is also blood -borne, often transmitted through shared needles.

But there's no vaccine for Hep C, is there?

There's no vaccine, but clinical pharmacology has achieved something really remarkable here.

The development of direct -acting antivirals means that Hep C is now entirely curable in the vast majority of patients.

Oh, wow.

That's amazing.

It really is.

They target specific steps in the viral life cycle to completely clear it from the liver.

Though, I should note, this treatment is typically managed postpartum.

Okay, makes sense.

Finally, we must understand human immunodeficiency virus, HIV.

This virus specifically targets and destroys CD4 T cells, right?

Slowly dismantling the immune system's ability to fight off even mild infections.

Exactly.

And because early intervention is absolutely life -saving, the CDC recommends opt -out screening for all patients, including pregnant women.

The diagnostic test looks for both the HIV antigen and the host's antibodies.

And the clinical algorithm for managing an HIV -positive pregnant patient is just a triumph of modern medicine.

The goal is to keep the maternal viral load so low that it cannot cross the placenta or infect the baby during birth.

Right.

So the patient takes oral antiretroviral therapy, or ART, throughout the entire pregnancy.

ART disrupts the virus's ability to copy its RNA into DNA, which drastically suppresses replication.

And then at 38 weeks, we check the viral load.

If there are more than 1 ,000 copies of the virus per milliliter of blood, the risk of transmission is too high, and scheduled C -section is required, right?

Correct.

But if the viral load is heavily suppressed, below 1 ,000 copies, a vaginal delivery may actually be safe.

That is amazing.

And during labor, we administer the cis -xetovudine to the mother, which rapidly crosses the placenta to provide a shield of antiviral medication directly inside the fetus.

What's fascinating here is how strictly following this algorithm has reduced perinatal HIV transmission to less than 2%.

Less than 2%.

That's incredible.

Now, postpartum, because the virus is concentrated in breast milk, breastfeeding is strictly contraindicated in the U .S., correct?

Yes, exactly.

Okay, so we've spent a lot of time on systemic severe pathogens.

Now we really need to look at localized vaginal infections.

These don't always make headlines, but they are the most frequent reason women seek gynecologic care.

Right, demystifying table 7 .2.

To understand the pathology here, you really have to understand the microscopic ecosystem of the vagina.

Oh, for sure.

I like to think of a healthy vaginal microbiome like an exclusive nightclub.

The dominant bacteria, the lactobacilli, they act as the club's bouncers.

They consume glycogen and produce lactic acid and hydrogen peroxide.

Right, and that keeps the environment highly acidic, a pH around 3 .8 to 4 .5.

That acidity is a chemical defense that prevents other, more rowdy microorganisms from multiplying and taking over the dance floor.

Exactly.

But when that acidic environment is disrupted, you get bacterial vaginosis, or BV.

In BV, the lactobacilli populations crash.

Without their acid production, the vaginal pH rises above 4 .5.

And this alkaline shift allows anaerobic bacteria, like Gardnerella, to just overgrow massively.

So when you analyze the vaginal discharge on a microscope slide using a saline wet mount, what are you looking for?

You're looking for clue cells.

These are normal epithelial cells that have been completely swarmed and coated by the overgrowing bacteria.

You also perform a whiff test.

Right, the whiff test.

Yeah, when you add a drop of potassium hydroxide, or KOH, to the slide, it volatilizes the amines produced by the anaerobic bacteria.

This releases a very distinct, sharp, fishy odor.

And to clear the dance floor and allow the lactobacilli to return, we treat BV with metronidazole, right?

Which specifically targets those anaerobic bacteria.

Exactly.

Now the second localized disruption is candidiasis, or a yeast infection.

The pathogen here is candida albicans, a fungus.

Yeast infections often occur when a patient takes a broad -spectrum antibiotic for an unrelated issue, like a sinus infection.

Because the antibiotic indiscriminately kills off the lactobacilli bouncers.

You got it.

Crucially, though, in a yeast infection, the vaginal pH generally remains normal.

The dominant symptoms are an intense, localized pruritus itching and a thick, lumpy white discharge.

And when you look at the discharge on a slide, you apply KOH again, right?

The KOH dissolves the human cellular debris but leaves the rigid fungal cell walls intact, allowing you to clearly see the hyphae and pseudohyphae.

They look kind of like branching microscopic tree roots.

We treat this with over -the -counter topical antifungals.

The third localized infection is trichomoniasis.

This is caused by a highly modal anaerobic protozoan.

It causes intense inflammation, resulting in a frothy, yellowish -green, malodorous discharge.

And during a speculum exam, you might see strawberry spots.

These tiny, hemorrhagic patechiae on the cervix caused by the parasite physically damaging the mucosal capillary.

Ouch.

And on a saline wet mount, you can literally see the protozoa swimming across the slide using their flagella.

We treat this with metronidazole, too, right?

We do.

But there is a vital clinical mandate here.

Trichomoniasis is highly transmissible.

You must instruct the patient that their male partner has to be treated simultaneously, even if he has zero symptoms.

Because if you only treat the female patient, the asymptomatic male will immediately pass the protozoan right back to her, creating this endless ping -pong cycle of reinfection.

Exactly.

Okay, having covered the pathogens in the adult body, we have to examine what happens when they breach the placental barrier.

When assessing neonatal risk, you'll frequently see orders for the Torchek Panel, which is table 7 .4 in the text.

Right, TRH.

This is an acronym for specific infections that can cross the placenta and interfere with fetal development.

Let's break it down.

T is for toxoplasmosis.

This is a systemic protozoan infection contracted by consuming undercooked meat or inadvertently ingesting infected cat feces, which is the exact biological reason pregnant individuals must avoid changing cat litter.

Precisely.

If the mother contracts it in the first trimester, the protozoan crosses the placenta and can cause severe central nervous system lesions and hydrocephalus in the developing fetus.

Wow.

Okay.

O stands for other infections, primarily hepatitis A and B, which we established can infect the fetal liver.

Right.

R is rubella, the German measles.

This virus is teratogenic because it actively inhibits mitosis or cell division in the developing fetus.

And if the fetus' cells cannot divide properly during the first trimester when organs are It results in profound structural anomalies, right, deafness, cataracts, and severe congenital heart defects.

It's devastating.

And because the rubella vaccine contains a live, attenuated virus, it could theoretically cross the placenta and cause these exact same anomalies.

Therefore, it is strictly contraindicated during pregnancy.

That's a massive clinical alert.

So nonimmune patients receive the vaccine postpartum and must be counseled to avoid pregnancy for at least one month.

Exactly.

Next, C is for cytomegalovirus, or CMV.

It's transmitted via close contact with bodily fluids.

When it crosses the placenta, it interferes with fetal development, causing hepatosplenomegaly, a massive enlargement of the liver and spleen, along with microcephaly and progressive hearing loss.

And finally, H stands for herpes simplex virus, reiterating the critical danger of viral shedding from active lesions during a vaginal delivery.

Right.

Now, as we step back from the path of physiology and look at public health management, we really have to talk about inclusive nursing practice.

There's this persistent, dangerous myth in health care that women who have sex with women, or WSW, do not contract STIs.

Which is just biologically false.

Biological fluids are biological fluids.

WSW populations are absolutely at risk for bacterial, viral, and protozoal transmission.

You can never let a patient's sexual orientation create a blind spot in your clinical assessment.

Never.

Open, routine, non -judgmental questioning ensures nobody slips through the cracks.

And finally, your role in epidemiology.

Syphilis, gonorrhea, chlamydia, and HIV are legally reportable diseases across the entire country.

The public health department uses this data to track and trace outbreaks.

And your ethical responsibility as a nurse is transparency.

You must inform your patient exactly why their data is being reported.

Explain that it's not a punitive measure, but a public health mandate to stop community transmission.

Transparency is how you maintain that therapeutic relationship.

We have covered a massive amount of clinical ground today.

We went from the structured safety check of the five P's into the ascending cellular destruction of bacterial STIs.

We shifted our paradigm to the lifelong viral suppression of HPV, HSV, and HIV.

We looked under the microscope at the volatile pH of the vaginal nightclub and finally mapped out how the TORCH pathogens cross the placenta to halt fetal development.

The key to mastering this material isn't rote memorization, you know, it's understanding the mechanisms.

When you know why the Jerrish -Herxheimer reaction happens or how an antibiotic destroys the vaginal lactobacilli, the interventions naturally make sense.

They really do.

Now, here's where it gets really interesting.

I want to leave you with a thought to mull over before your next exam.

We've spent this entire session talking about how we use chemicals and antibiotics to kill off these microscopic threats.

But what if the simple act of taking a thorough, non -judgmental sexual history isn't just about filling out a chart?

Right.

What if it's more than that?

Exactly.

What if it is the literal front line of defense?

A simple conversation could prevent irreversible neonatal blindness from gonorrhea, halt an ectopic pregnancy from PID, or stop the generational transmission of HIV.

It's so true.

The clipboard really is as powerful as the stethoscope.

And beyond that, researchers are currently looking at how we might genetically engineer those lactobacilli, the bouncers in the vaginal nightclub.

Imagine a future where we use a targeted probiotic to colonize the body with a super -strain of bacteria that naturally secretes its own antiviral microbicides, neutralizing HIV or gonorrhea upon entry.

Without relying on a patient remembering to take a pill or negotiate condom use, we might eventually fight the bugs with better bugs.

The clinical landscape is always evolving, and understanding this foundational pathophysiology is what will allow you to adapt to those future breakthroughs.

You are stepping into a field where your ability to synthesize this knowledge, ask the right questions without judgment, and educate your patients is just as powerful as the medications you administer.

On behalf of the Last Minute Lecture team, thank you so much for studying with us today.

We are so proud of the work you're doing, and we wish you the absolute best of luck on your exams and in your clinical rotations.

You've got this.